An Evaluation of Direct-to-Consumer Pulse Oximetry Devices
How reliable are the 10 most popular consumer pulse oximeters used for home monitoring?
All articles by Bryant Moeller
HScore as a Predictor for Severe COVID-19 Outcomes
An Iranian study assessed whether HScores predicted outcomes in severe COVID-19 and could thus be used to guide early treatment decisions.
Factors linked to Magnitude of Antibody Response After SARS-CoV-2 Infection
Using a cohort of healthcare workers, researchers identified ethnodemographic correlates of serological responses against the SARS-CoV-2 spike glycoprotein.
Factors Linked to Mortality in Invasively Ventilated Patients With COVID-19
The prospective SATICOVID19 study provides a detailed analysis of characteristics of invasively ventilated patients with COVID-19 in 63 ICUs in Argentina.
Ethnic Disparities in Influenza-Associated Hospitalization and Death
Analysis of 10 years of data revealed that racial and ethnic minorities experienced more adverse outcomes from severe influenza.
Real-World Study Compares 2 Long-Acting β2-Agonists for Asthma Control
A large, retrospective study compared the asthma control effectiveness of once-daily fluticasone furoate/vilanterol vs twice-daily budesonide/formoterol.
Polygenic Risk Scores and COPD History Predict COVID-19 Disease Severity
In this study, the researchers explored the potential interaction between genetic risk and chronic obstructive pulmonary disease in relation to severe COVID-19.
Comparing Treatment Strategies to Achieve Culture Conversion in MAC Lung Disease
Patients with treatment-refractory Mycobacterium avium complex (MAC) lung disease who received amikacin liposome inhalation suspension and guideline therapy had increased culture conversion compared with guideline therapy alone.
Patient-Directed Prone Positioning Is Not Feasible in COVID-19
Patient-directed prone positioning is not feasible in spontaneously breathing, nonintubated patients hospitalized with COVID-19.
MAC Risk in Patients With Bronchiectasis on Long-Term Macrolide Therapy
Patients with bronchiectasis on long term macrolide therapy were at low risk of developing macrolide-resistant Mycobacterium avium complex (MAC) disease.
- Loading...
Loading...
Next post in General Infectious Disease
Loading... 
Loading...